BNC Korea Co., Ltd. (KOSDAQ: 256840)

Market Cap	278.40B
Revenue (ttm)	83.78B
Net Income (ttm)	21.31B
Shares Out	66.44M
EPS (ttm)	274.13
PE Ratio	15.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	493,107
Open	4,095.00
Previous Close	4,135.00
Day's Range	4,020.00 - 4,195.00
52-Week Range	3,295.00 - 9,410.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About BNC Korea

BNC Korea Co., Ltd. engages in the research and development, production, and sale of biomaterials in South Korea. The company offers HA fillers and skin booster fillers, including Cutegel, Cutegel Lidocaine, FLORE Lidocaine, ChungA-an, CUTEGEL-M, Cutegel Hydro, S-DNA, and H-DNA, which are used to temporarily reduce facial wrinkles through physical restoration. It also provides Hibarry, a dressing for deep-cavity wounds that is used to reduce adhesion of the spinal cord during surgery; GENTA Q, a white collagen sponge, which is used to protect w...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2007
• Employees: 193
• Stock Exchange: KOSDAQ
• Ticker Symbol: 256840